Search results
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 3 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine, announced ...
What to know about Moderna’s combined covid-flu vaccine on the horizon
Boston.com· 2 days agoModerna’s combined coronavirus-influenza shot reportedly produced a higher immune response in older...
Column: After smearing Anthony Fauci, House Republicans proceed to defame a prominent vaccine...
Los Angeles Times· 7 days agoPeter J. Hotez is one of America’s most prominent vaccine experts. A professor at Baylor College of...
Moderna to present combo COVID-flu vaccine to regulators after trial
AOL· 3 days agoModerna announced on Monday that its combination COVID-19 and flu mRNA-1083vaccine trial showed "promising" results and that the company would soon present its findings to regulators for next ...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 3 days agoThe ongoing clinical trial pits this new combination shot, called mRNA-1083, against several licensed vaccines that protect against either COVID-19 or the flu. Compared with ...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 3 days agoCompared with these separate vaccines, the combo shot produced "significantly higher immune...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 3 days agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 2 days agoNovavax Novavax (NASDAQ: NVAX) actually has gotten a start along the path to gains, soaring more...
FDA tells Covid-19 vaccine makers to update shot to target current virus variant
WKBT La Crosse· 6 days agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
Moderna to present combo COVID-flu vaccine to regulators after trial
Scripps News via AOL· 3 days agoBuilding on the momentum of positive Phase 3 data across our respiratory portfolio, we continue to...